Jet.AI Announces Pricing of $1.5 Million Registered Direct Offering
October 18, 2024 14:00 ET
|
Jet.AI Inc.
LAS VEGAS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation and artificial intelligence company, today announced that it has...
Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants
October 15, 2024 08:30 ET
|
Rani Therapeutics, LLC
SAN JOSE, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
October 14, 2024 16:15 ET
|
Heart Test Laboratories, Inc.
Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered...
Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
October 14, 2024 08:00 ET
|
Bionomics Ltd
ADELAIDE, Australia and CAMBRIDGE, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel,...
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024
October 11, 2024 08:00 ET
|
Assertio Holdings, Inc.
LAKE FOREST, Ill., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Jet.AI Announces Pricing of $2.4 Million Registered Direct Offering
October 10, 2024 14:41 ET
|
Jet.AI Inc.
LAS VEGAS, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Jet.AI Inc. (“Jet.AI” or the “Company”) (NASDAQ: JTAI), an innovative private aviation and artificial intelligence company, today announced that it has...
Zevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
October 10, 2024 07:30 ET
|
Zevra Therapeutics
CELEBRATION, Fla., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that Neil F. McFarlane,...
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events
October 10, 2024 07:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Oct. 10, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem...
Ocugen to Participate in 2024 Maxim Healthcare Virtual Summit
October 10, 2024 07:00 ET
|
Ocugen
MALVERN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
October 10, 2024 07:00 ET
|
Aclarion, Inc.
Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024 BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare...